UPDATE 1-Safety data on AstraZeneca anaemia drug points to potential use in dialysis

Επιχειρήσεις

08 Νοεμβρίου 2019

AstraZeneca said that safety data on roxadustat underpinned the British drugmaker's hopes for the anaemia drug to become a standard treatment for patients with kidney disease.

Δείτε περισσότερα: Reuters.com

ΙΑΝΟΥΑΡΙΟΣ - ΜΑΡΤΙΟΣ 2016

ΤΕΥΧΟΣ

43

Α. Τσίπρας, Κ. Μητσοτάκης, EITO, Cisco, Accenture, PwC, IDC, WEF, Focus Bari

ΗΜΕΡΟΛΟΓΙΟ ΕΚΔΗΛΩΣΕΩΝ